Home » Stocks » MD

MEDNAX, Inc. (MD)

Stock Price: $21.33 USD 0.31 (1.47%)
Updated December 3, 11:21 AM EST - Market open

Stock Price Chart

Key Info

Market Cap 1.83B
Revenue (ttm) 2.72B
Net Income (ttm) -722.86M
Shares Out 83.86M
EPS (ttm) -8.71
PE Ratio n/a
Forward PE 11.24
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $21.33
Previous Close $21.02
Change ($) 0.31
Change (%) 1.47%
Day's Open 21.00
Day's Range 20.61 - 21.43
Day's Volume 101,041
52-Week Range 7.89 - 28.40

More Stats

Market Cap 1.83B
Enterprise Value 3.25B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 83.86M
Float n/a
EPS (basic) -22.85
EPS (diluted) -8.71
FCF / Share 3.76
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 17.28%
Payout Ratio n/a
Shares Short 9.88M
Short Ratio 5.45
Short % of Float n/a
Beta 1.65
PE Ratio n/a
Forward PE 11.24
P/FCF Ratio 5.79
PS Ratio 0.67
PB Ratio 2.14
Revenue 2.72B
Operating Income 133.24M
Net Income -722.86M
Free Cash Flow 315.43M
Net Cash -1.43B
Net Cash / Share -16.68
Gross Margin 25.42%
Operating Margin 4.90%
Profit Margin -26.60%
FCF Margin 11.59%
ROA 6.02%
ROE -104.75%
ROIC -19.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (12)

Buy 2
Overweight 0
Hold 7
Underweight 1
Sell 2

Analyst Consensus: Hold

Price Target

$19.00*
(-10.92% downside)
Low
14.0
Current: $21.33
High
25.0
Target: 19.00
*Average 12-month price target from 11 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,5143,4553,2533,1832,7802,4392,1541,8171,5881,402
Revenue Growth1.7%6.19%2.21%14.5%13.99%13.23%18.57%14.38%13.32%-
Gross Profit8929209201,034928807710614551489
Operating Income-1,136432455572558513452390355313
Net Income-1,498269320325336317281241218203
Shares Outstanding83.5091.1092.4392.4293.0898.5999.1197.3995.4193.26
Earnings Per Share-13.782.823.293.493.583.182.782.422.232.13
EPS Growth--14.29%-5.73%-2.51%12.58%14.39%14.88%8.52%4.69%-
Operating Cash Flow347290511444369423405325271241
Capital Expenditures-31.88-30.48-26.15-39.26-27.07-18.06-15.65-14.50-31.33-12.11
Free Cash Flow315259485405342405390310239228
Cash & Equivalents18267.4190.4966.9860.4353.9637.5927.8622.7443.63
Total Debt1,8071,9751,8531,7061,27556927.2414429.47147
Net Cash / Debt-1,625-1,907-1,762-1,639-1,214-51510.36-116-6.74-103
Assets4,1465,9375,8675,3394,5473,6083,0092,7502,2732,038
Liabilities2,6472,8502,8012,5792,1091,343666715542590
Book Value1,4993,0883,0662,7612,4382,2652,3432,0351,7311,447
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MEDNAX, Inc.
Employees 9,480

Stock Information

Ticker Symbol MD
Stock Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NYSE: MD
IPO Date September 19, 1995

Description

MEDNAX, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, pediatric ophthalmology, other newborn pediatric care, and newborn hearing screening program, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it offers consulting services to healthcare facilities and physicians. As of March 12, 2020, the company operated a network of approximately 4,325 physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.